↓ Skip to main content

Study protocol of REGOSARC trial: activity and safety of regorafenib in advanced soft tissue sarcoma: a multinational, randomized, placebo-controlled, phase II trial

Overview of attention for article published in BMC Cancer, March 2015
Altmetric Badge

Citations

dimensions_citation
22 Dimensions

Readers on

mendeley
47 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Study protocol of REGOSARC trial: activity and safety of regorafenib in advanced soft tissue sarcoma: a multinational, randomized, placebo-controlled, phase II trial
Published in
BMC Cancer, March 2015
DOI 10.1186/s12885-015-1143-y
Pubmed ID
Authors

Thomas Brodowicz, Bernadette Liegl-Atzwager, Emmanuelle Tresch, Sophie Taieb, Andrew Kramar, Viktor Gruenwald, Marie Vanseymortier, Stéphanie Clisant, Jean-Yves Blay, Axel Le Cesne, Nicolas Penel

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 47 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 47 100%

Demographic breakdown

Readers by professional status Count As %
Researcher 8 17%
Other 7 15%
Student > Master 6 13%
Student > Bachelor 5 11%
Student > Ph. D. Student 4 9%
Other 7 15%
Unknown 10 21%
Readers by discipline Count As %
Medicine and Dentistry 17 36%
Biochemistry, Genetics and Molecular Biology 4 9%
Agricultural and Biological Sciences 3 6%
Nursing and Health Professions 2 4%
Engineering 2 4%
Other 7 15%
Unknown 12 26%